HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Increased expression of OLFM4 and lysozyme during necrotizing enterocolitis in neonates: an observational research study.

AbstractBACKGROUND:
In neonatal patients with necrotizing enterocolitis (NEC) the inflammatory response is mediated by a plurality of different proteins. The proteins olfactomedin 4 (OLFM4) and lysozyme (LYZ) are part of the intestinal mucosal defense and especially OLFM4 has rarely been evaluated in neonatal gastrointestinal diseases. The aim of this study was to analyze whether expression levels of both proteins of innate immunity, OLFM4 and lysozyme, were increased during NEC in neonates.
METHODS:
Intestinal tissues of patients with NEC were examined with immunohistochemical staining of formalin-fixed and paraffin-embedded sections of resected tissue using antibodies against OLFM4 and lysozyme. Staining-positive tissues were semi-quantitatively scored from 0 (no staining), 1 (weak staining), 2 (moderate staining) to 3 (highly intense staining) by two individual investigators. Intestinal tissue of infants with volvulus was used as a control as other intestinal tissue without major inflammation was not available.
RESULTS:
Both applied antibodies against OLFM4 showed different staining patterns with higher staining intensity of the antibody OLFM4 (D1E4M). OLFM4 (median score of the antibody OLFM4 (D1E4M): 3.0) and lysozyme (median score: 3.0) are highly expressed in intestinal and immune cells during NEC. Expression of OLFM4 and lysozyme in the control samples with volvulus was observable but significantly lower (median score of the antibody OLFM4 (D1E4M): 1.25; median score of the antibody against LYZ: 2.0; p = 0.033 and p = 0.037, respectively).
CONCLUSIONS:
Both proteins, OLFM4 and lysozyme, may play a role in the pathogenesis of NEC in neonatal patients, but the exact mechanisms of OLFM4 and lysozyme function and their role in immunological responses have not yet been resolved in detail. These observations add new insights as basis for further large-scale population research.
AuthorsSonja Diez, Marcus Renner, Veronika Bahlinger, Arndt Hartmann, Manuel Besendörfer, Hanna Müller
JournalBMC pediatrics (BMC Pediatr) Vol. 22 Issue 1 Pg. 192 (04 11 2022) ISSN: 1471-2431 [Electronic] England
PMID35410162 (Publication Type: Journal Article, Observational Study)
Copyright© 2022. The Author(s).
Chemical References
  • OLFM4 protein, human
  • Proteins
  • Granulocyte Colony-Stimulating Factor
  • Muramidase
Topics
  • Enterocolitis, Necrotizing (etiology)
  • Fetal Diseases
  • Granulocyte Colony-Stimulating Factor
  • Humans
  • Infant
  • Infant, Newborn
  • Infant, Newborn, Diseases
  • Intestinal Mucosa (metabolism)
  • Intestinal Volvulus (complications)
  • Muramidase
  • Proteins

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: